Plain-English translation of NCT05872724 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new approach to treating cervical cancer after surgery. Instead of giving all patients the same treatment, doctors will use special blood tests to identify tiny amounts of remaining cancer cells, then tailor the treatment plan accordingly. The goal is to give patients the right level of treatment—avoiding unnecessary side effects for some while ensuring others get intensive therapy when needed.
After surgery for cervical cancer, doctors typically give all patients similar follow-up treatment, even though not all patients have the same risk of cancer returning. This study exists to see whether using blood tests to detect microscopic cancer cells can help doctors personalize treatment so that each patient gets exactly what they need.
You likely qualify if…
You likely don't qualify if…
You will have blood tests taken shortly after your surgery to look for cancer markers. Based on these results and your cancer stage, you'll be assigned to one of two treatment groups. Both groups receive radiation and chemotherapy combined with immunotherapy (a type of treatment that helps your immune system fight cancer). Depending on your group and what your blood tests show, you may receive additional immunotherapy. You'll return to the hospital for safety check-ins after treatment ends, then have follow-up visits every three months for imaging scans and monitoring.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
China